Latest News & Updates
Breaking News
8 hours ago
Vaibhavi M.
Other trending news you may like to read
EDP-978 Shows Strong Preclinical Profile As Enanta Prepares American Academy of Allergy, Asthma & Immunology(AAAAI) Presentations
Enanta to present preclinical AAAAI 2026 data showing strong potency and PK profile for EDP-978 in Type 2 inflammatory diseases.
Vaibhavi M.
FDA Grants Priority Review To Takeda’s Oveporexton NDA For Narcolepsy Type 1 Treatment
FDA grants Priority Review to Takeda’s oveporexton NDA, targeting the root cause of narcolepsy type 1 via orexin signaling.
Vaibhavi M.
Chugai Expands Oncology Alliance With Araris To Develop Next-Generation Antibody-Drug Conjugates
Chugai expands its oncology alliance with Araris, licensing AraLinQ technology to develop next-generation antibody-drug conjugates.
Vaibhavi M.
20260211170842.png)
FDA Greenlights Medicus’ Phase 2b Study Of Teverelix, A Next-Generation GnRH Antagonist For Advanced Prostate Cancer
FDA clears Medicus Pharma’s Phase 2b study of Teverelix, a long-acting GnRH antagonist for advanced prostate cancer.
Vaibhavi M.
